BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tsekovska R, Sredovska-Bozhinov A, Niwa T, Ivanov I, Mironova R. Maillard reaction and immunogenicity of protein therapeutics. World J Immunol 2016; 6(1): 19-38 [DOI: 10.5411/wji.v6.i1.19]
URL: https://www.wjgnet.com/2219-2824/full/v6/i1/19.htm
Number Citing Articles
1
Misganaw Asmamaw Mengstie, Endeshaw Chekol Abebe, Awgichew Behaile Teklemariam, Anemut Tilahun Mulu, Melaku Mekonnen Agidew, Muluken Teshome Azezew, Edgeit Abebe Zewde, Assefa Agegnehu Teshome. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complicationsFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1002710
2
Alexandre Ambrogelly. The Different Colors of mAbs in SolutionAntibodies 2021; 10(2): 21 doi: 10.3390/antib10020021
3
Shravan Sreenivasan, Christian Schöneich, Anurag S. Rathore. Aggregation of therapeutic monoclonal antibodies due to thermal and air/liquid interfacial agitation stress: Occurrence, stability assessment strategies, aggregation mechanism, influencing factors, and ways to enhance stabilityInternational Journal of Pharmaceutics 2024; 666: 124735 doi: 10.1016/j.ijpharm.2024.124735
4
W Khoirunnisa, M I Nur, S Widyarti, S Permana, S B Sumitro. Physiologic Glycated-Bovine Serum Albumin Determination using Spectrum-UVJournal of Physics: Conference Series 2019; 1241(1): 012003 doi: 10.1088/1742-6596/1241/1/012003
5
Yanchi Chen, Zihan Meng, Yong Li, Shibo Liu, Pei Hu, En Luo. Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complicationsMolecular Medicine 2024; 30(1) doi: 10.1186/s10020-024-00905-9